Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Molecular hydrogen in drinking water protects against neurodegenerative changes induced by traumatic brain injury.

Dohi K, Kraemer BC, Erickson MA, McMillan PJ, Kovac A, Flachbartova Z, Hansen KM, Shah GN, Sheibani N, Salameh T, Banks WA.

PLoS One. 2014 Sep 24;9(9):e108034. doi: 10.1371/journal.pone.0108034. eCollection 2014.

2.

Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cells.

Erickson MA, Morofuji Y, Owen JB, Banks WA.

J Pharmacol Exp Ther. 2014 Jun;349(3):497-507. doi: 10.1124/jpet.114.213074. Epub 2014 Apr 4.

4.

Cardiorenal metabolic syndrome and diabetic cognopathy.

Hayden MR, Banks WA, Shah GN, Gu Z, Sowers JR.

Cardiorenal Med. 2013 Dec;3(4):265-82. doi: 10.1159/000357113. Epub 2013 Nov 29.

6.

SAMP8 mice have altered hippocampal gene expression in long term potentiation, phosphatidylinositol signaling, and endocytosis pathways.

Armbrecht HJ, Siddiqui AM, Green M, Farr SA, Kumar VB, Banks WA, Patrick P, Shah GN, Morley JE.

Neurobiol Aging. 2014 Jan;35(1):159-68. doi: 10.1016/j.neurobiolaging.2013.07.018. Epub 2013 Aug 19.

7.

Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.

Erickson MA, Banks WA.

J Cereb Blood Flow Metab. 2013 Oct;33(10):1500-13. doi: 10.1038/jcbfm.2013.135. Epub 2013 Aug 7. Review.

9.

Somatostatin receptor subtype-4 agonist NNC 26-9100 mitigates the effect of soluble Aβ(42) oligomers via a metalloproteinase-dependent mechanism.

Sandoval KE, Farr SA, Banks WA, Crider AM, Morley JE, Witt KA.

Brain Res. 2013 Jul 3;1520:145-56. doi: 10.1016/j.brainres.2013.05.006. Epub 2013 May 10.

10.

Dietary components in the development of leptin resistance.

Vasselli JR, Scarpace PJ, Harris RB, Banks WA.

Adv Nutr. 2013 Mar 1;4(2):164-75. doi: 10.3945/an.112.003152. Review.

11.
12.

Pharmacological inhibition of mitochondrial carbonic anhydrases protects mouse cerebral pericytes from high glucose-induced oxidative stress and apoptosis.

Shah GN, Price TO, Banks WA, Morofuji Y, Kovac A, Ercal N, Sorenson CM, Shin ES, Sheibani N.

J Pharmacol Exp Ther. 2013 Mar;344(3):637-45. doi: 10.1124/jpet.112.201400. Epub 2012 Dec 17.

13.

Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo.

Tong J, Yi X, Luxenhofer R, Banks WA, Jordan R, Zimmerman MC, Kabanov AV.

Mol Pharm. 2013 Jan 7;10(1):360-77. doi: 10.1021/mp300496x. Epub 2012 Dec 17.

14.

Pharmacokinetics and modeling of immune cell trafficking: quantifying differential influences of target tissues versus lymphocytes in SJL and lipopolysaccharide-treated mice.

Banks WA, Niehoff ML, Ponzio NM, Erickson MA, Zalcman SS.

J Neuroinflammation. 2012 Oct 3;9:231. doi: 10.1186/1742-2094-9-231.

15.

Ischemia-reperfusion impairs blood-brain barrier function and alters tight junction protein expression in the ovine fetus.

Chen X, Threlkeld SW, Cummings EE, Juan I, Makeyev O, Besio WG, Gaitanis J, Banks WA, Sadowska GB, Stonestreet BS.

Neuroscience. 2012 Dec 13;226:89-100. doi: 10.1016/j.neuroscience.2012.08.043. Epub 2012 Sep 15.

16.

Soluble interleukin-6 receptor induces motor stereotypies and co-localizes with gp130 in regions linked to cortico-striato-thalamo-cortical circuits.

Patel A, Zhu Y, Kuzhikandathil EV, Banks WA, Siegel A, Zalcman SS.

PLoS One. 2012;7(7):e41623. doi: 10.1371/journal.pone.0041623. Epub 2012 Jul 23.

17.

Protective effects of an anti-melanocortin-4 receptor scFv derivative in lipopolysaccharide-induced cachexia in rats.

Peter JC, Rossez H, Weckering M, Zipfel G, Lecourt AC, Owen JB, Banks WA, Hofbauer KG.

J Cachexia Sarcopenia Muscle. 2013 Mar;4(1):79-88. doi: 10.1007/s13539-012-0084-4. Epub 2012 Aug 22.

18.

Insulin in the brain: there and back again.

Banks WA, Owen JB, Erickson MA.

Pharmacol Ther. 2012 Oct;136(1):82-93. doi: 10.1016/j.pharmthera.2012.07.006. Epub 2012 Jul 17. Review.

19.

Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine.

Erickson MA, Hansen K, Banks WA.

Brain Behav Immun. 2012 Oct;26(7):1085-94. doi: 10.1016/j.bbi.2012.07.003. Epub 2012 Jul 15.

20.

Brain meets body: the blood-brain barrier as an endocrine interface.

Banks WA.

Endocrinology. 2012 Sep;153(9):4111-9. doi: 10.1210/en.2012-1435. Epub 2012 Jul 9. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk